LYRA THERAPEUTICS INC's ticker is LYRA and the CUSIP is 55234L105. A total of 32 filers reported holding LYRA THERAPEUTICS INC in Q1 2023. The put-call ratio across all filers is 0.12 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $222,905 | +82.5% | 57,009 | +91.9% | 0.00% | – |
| Q2 2023 | $122,120 | +103.7% | 29,713 | -0.4% | 0.00% | – |
| Q1 2023 | $59,956 | -36.0% | 29,829 | 0.0% | 0.00% | – |
| Q4 2022 | $93,663 | -37.1% | 29,829 | 0.0% | 0.00% | – |
| Q3 2022 | $149,000 | -11.8% | 29,829 | 0.0% | 0.00% | – |
| Q2 2022 | $169,000 | -77.3% | 29,829 | -53.7% | 0.00% | – |
| Q1 2021 | $746,000 | -3.7% | 64,451 | -5.2% | 0.00% | – |
| Q4 2020 | $775,000 | +41.7% | 67,995 | +39.1% | 0.00% | – |
| Q3 2020 | $547,000 | -6.8% | 48,887 | -5.7% | 0.00% | – |
| Q2 2020 | $587,000 | – | 51,857 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Polaris Venture Management Co. V, L.L.C. | 1,100,852 | $12,550,000 | 16.38% |
| Soleus Capital Management, L.P. | 456,138 | $5,199,000 | 0.69% |
| Ikarian Capital, LLC | 815,364 | $9,295,000 | 0.41% |
| Perceptive Advisors | 3,222,561 | $36,737,000 | 0.39% |
| Affinity Asset Advisors, LLC | 50,000 | $570,000 | 0.30% |
| RA Capital Management | 815,849 | $9,301,000 | 0.13% |
| ArrowMark Colorado Holdings LLC | 775,888 | $8,845,000 | 0.07% |
| BOOTHBAY FUND MANAGEMENT, LLC | 87,353 | $996,000 | 0.04% |
| Altium Capital Management LP | 5,218 | $59,000 | 0.02% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 49,000 | $559,000 | 0.01% |